Ex parte CLARKSON et al. - Page 4




          Appeal No. 1996-2558                                                        
          Application 08/152,099                                                      


          complete absence of CBH I type components and that, therefore,              
          appellants’ claimed invention is anticipated by Schülein                    
          (answer, pages 3-4).  The examiner’s argument is not                        
          persuasive because the examiner has not established that a                  
          composition which has “essentially no cellobiohydrolase                     
          activity” as disclosed by Schülein is free of all CBH I type                
          components as required by appellants’ claim 1.  Schülein’                   
          composition which has “essentially no cellobiohydrolase                     
          activity” could have some CBH I type components present, but                
          in an amount which provides a cellobiohydrolase activity below              
          0.5 PNP-Cel/mg.  Consequently, the examiner has not                         
          established that Schülein discloses each element of                         
          appellants’ claimed composition and, therefore, has not set                 
          forth a prima facie case of anticipation.                                   
                           Rejection under 35 U.S.C. § 103                            
               The examiner argues that Schülein teaches that using a                 
          cellulase enzyme having a high percentage of EG type                        
          components has the advantages of fabric softening and color                 
          clarification and that, therefore, one of ordinary skill in                 
          the art would have been motivated to use in the composition                 


                                          4                                           





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007